Abstract:Abstract Background The CRISPR-Cas12a (formerly Cpf1) system is a versatile gene-editing tool with properties distinct from the broadly used Cas9 system. Features such as recognition of T-rich protospacer-adjacent motif (PAM) and generation of sticky breaks, as well as amenability for multiplex editing in a single crRNA and lower off-target nuclease activity, broaden the targeting scope of available tools and enable more accurate genome editing. However, the widespread use of the nuclease for gene editing, especially in clinical applications, is hindered by insufficient activity and specificity despite previous efforts to improve the system. Currently reported Cas12a variants achieve high activity with a compromise of specificity. Here, we used structure-guided protein engineering to improve both editing efficiency and targeting accuracy of Acidaminococcus sp. Cas12a ( As Cas12a) and Lachnospiraceae bacterium Cas12a ( Lb Cas12a). Results We created new As Cas12a variant termed “ As Cas12a-Plus” with increased activity (1.5~2.0-fold improvement) and specificity (reducing off-targets from 29 to 23 and specificity index increased from 92% to 94% with 33 sgRNAs), and this property was retained in multiplex editing and transcriptional activation. When used to disrupt the oncogenic BRAF V600E mutant, As Cas12a-Plus showed less off-target activity while maintaining comparable editing efficiency and BRAF V600E cancer cell killing. By introducing the corresponding substitutions into Lb Cas12a, we also generated Lb Cas12a-Plus (activity improved ~1.1-fold and off-targets decreased from 20 to 12 while specificity index increased from 78% to 89% with 15 sgRNAs), suggesting this strategy may be generally applicable across Cas12a orthologs. We compared Cas12a-Plus, other variants described in this study, and the reported enCas12a-HF, enCas12a, and Cas12a-ultra, and found that Cas12a-Plus outperformed other variants with a good balance for enhanced activity and improved specificity. Conclusions Our discoveries provide alternative As Cas12a and Lb Cas12a variants with high specificity and activity, which expand the gene-editing toolbox and can be more suitable for clinical applications.

Genome editing with natural and engineered CjCas9 orthologs

Versatile and Efficient Genome Editing with Neisseria Cinerea Cas9

Harnessing accurate non-homologous end joining for efficient precise deletion in CRISPR/Cas9-mediated genome editing

Enhanced Mammalian Genome Editing by New Cas12a Orthologs with Optimized Crrna Scaffolds

CRISPR-Cas12a System With Synergistic Phage Recombination Proteins for Multiplex Precision Editing in Human Cells

Discovery and engineering of ChCas12b for precise genome editing

Compact Cje3Cas9 for Efficient in Vivo Genome Editing and Adenine Base Editing.

High-Throughput Profiling of Cas12a Orthologues and Engineered Variants for Enhanced Genome Editing Activity

Two Compact Cas9 Ortholog-Based Cytosine Base Editors Expand the DNA Targeting Scope and Applications In Vitro and In Vivo

Improving Plant Genome Editing with High-Fidelity Xcas9 and Non-canonical PAM-Targeting Cas9-NG

Evolved Cas9 variants with broad PAM compatibility and high DNA specificity

Engineering of a high-fidelity Cas12a nuclease variant capable of allele-specific editing

Engineered Cas12a-Plus nuclease enables gene editing with enhanced activity and specificity

Engineered CRISPR-Cas9 nuclease with expanded targeting space

Compact SchCas9 Recognizes the Simple NNGR PAM

Versatile and Efficient in Vivo Genome Editing with Compact Streptococcus Pasteurianus Cas9.

Deleting Specific Residues From the HNH Linkers Creates A CRISPR-SpCas9 Variant With High Fidelity and Efficiency

Chimeric CRISPR-CasX enzymes and guide RNAs for improved genome editing activity

Engineered CRISPR-Cas9 nucleases with altered PAM specificities

A highly specific CRISPR-Cas12j nuclease enables allele-specific genome editing

Engineered Campylobacter jejuni Cas9 variant with enhanced activity and broader targeting range